BioCentury
ARTICLE | Distillery Therapeutics

Cancer

January 31, 2017 11:06 PM UTC

Patient sample and mouse studies suggest inhibiting CD99 could help treat AML and MDS. Levels of CD99 were higher in hematopoietic stem cells (HSCs) from MDS patients and blasts from AML patients than...

BCIQ Target Profiles

CD99